ArticleFrontiers in cell and developmental biology2025
Revealing age-related changes in the intraocular microenvironment and senescence modulators using aqueous humor proteomics and machine learning.
Article in Frontiers in cell and developmental biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In conjunction with age, aqueous humor (AH) proteomics can affect the occurrence and development of age-related eye diseases, which are poorly understood. Objective: We characterized the proteomic changes in AH throughout the aging process to better understand the aging mechanisms of the intraocular environment. Methods: We analyzed the AH proteomes of 33 older and 19 younger individuals using liquid chromatography-tandem mass spectrometry, from which we clustered similar expression trajectories of AH proteomics using local regression analysis. Aging proteins (APs) and their functional enrichment were evaluated using various statistical and bioinformatics methods, while aging modulators were predicted using multiple machine-learning models. Results: AH proteomic expression patterns exhibited various types of linear and nonlinear changes across the age groups. A set of 179 proteins identified as significant APs were enriched in various eye processes, such as detoxification, eye development, negative regulation of hydrolase activity, and humoral immune response. According to AH proteomics, hallmarks of aging include oxidative damage, defective extracellular matrices, and loss of proteostasis. A total of 11 APs were considered senescence signatures for predicting AH age with strong predictive ability. Furthermore, 22 APs were classified as modulators that may affect the aging process in the eye. Conclusion: These findings establish a framework for age-related changes in the AH proteome and provide potential senescence biomarkers and therapeutic targets for age-related eye diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.